Avenue Therapeutics

$5.93
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.46 (-7.20%) Today
$0.00 (0.00%) As of 9:29 PM UTC after-hours

Why Robinhood?

You can buy or sell ATXI and other stocks, options, and ETFs commission-free!

About ATXI

Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately severe post-operative pain. The company was founded on February 9, 2015 and is headquartered in New York, NY. The listed name for ATXI is Avenue Therapeutics, Inc. Common Stock.

CEO
Lucy Lu
Employees
4
Headquarters
New York, New York
Founded
2015
Market Cap
75.78M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
316.94K
High Today
$6.45
Low Today
$5.75
Open Price
$6.39
Volume
165.77K
52 Week High
$12.34
52 Week Low
$2.85

ATXI Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 29, After Hours

You May Also Like

AJXA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure